iQIYI (NASDAQ:IQ) Bolsa

IQIYI INC-ADR

iQIYI

Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

SCOR

SGRP

Las acciones más sobrevendidas en tecnología y telecomunicaciones con RSI bajo 30, una oportunidad para invertir en empresas infravaloradas.

3 acciones de tecnología y telecomunicaciones que podrían salvar tu cartera este mes

iQIYI Inc

Everipedia

IMAGING BIOMETRICS LTD by Imaging Biometrics Ltd

Imaging Biometrics Ltd

FlexShares Trust Intl Quality Dividend Defensive Index Fd

FlexShares International Quality Dividend Index Fund

WisdomTree International Quality Dividend Growth Fund

FlexShares International Quality Dividend Dynamic Index Fund

IQE PLC

IQGeo Group PLC

NYLI MacKay High Income ETF

Invesco Quality Municipal Income Trust Common Stock

Invesco Quality Municipal Income Trust

IndexIQ ETF Trust NYLI 500 International ETF

iShares MSCI Intl Quality Factor ETF

Franklin Intelligent Machines ETF

IQeon

Inteliqo Ltd

ProShares Nasdaq-100 High Income ETF

NYLI CBRE Real Assets ETF

NYLI Candriam International Equity ETF

NYLI Candriam U.S. Mid Cap Equity ETF

iQSTEL Inc

NYLI Candriam U.S. Large Cap Equity ETF

IQVIA Holdings Inc

iQ International AG

WKSP

Worksport Announces  Nano-Grid System Pilot With A US Construction Group

DA Davidson analyst Gil Luria initiates coverage on ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Buy rating and announces Price Target of $1150.

Price Target

Initiation

Analyst Ratings

DA Davidson Initiates Coverage On ServiceNow with Buy Rating, Announces Price Target of $1150

Femasys Inc., (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products, announces Conformité Européene (CE) mark certification under European Union Medical Device Regulation (EU MDR 2017/745) of the Class III FemBloc blended polymer component, marking the first regulatory approval in the world for the FemBloc&#xAE; System for non-surgical female permanent birth control. After European Medicines Agency (EMA) review, the Notified Body has granted CE mark certification. The regulatory approval for the blended polymer joins the earlier approval announced on March 13, 2025 for the delivery system component of FemBloc. The FemBloc System can now be marketed in the European Economic Area, which includes the 27 member states of the European Union and the 3 European Free Trade Association countries.

FEMY

Femasys Announces CE Mark Certification Under European Union Medical Device Regulation Of Class III FemBloc Blended Polymer Component

Eco Wave Power Global AB (publ) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAVE#NASDAQ">WAVE</a>), a leading onshore wave energy developer, is pleased to announce that Inna Braverman, Founder and CEO of Eco Wave Power, and Ran Atias, VP of Engineering, held a strategic meeting with Terry Tamminen, CEO of AltaSea at the Port of Los Angeles, to officially agree upon the launch date and public unveiling of the first-ever onshore U.S. wave energy pilot project.
The historic launch event is scheduled to take place on Tuesday, September 9, 2025, on-site at AltaSea, and will mark a historic milestone in renewable energy innovation for the United States. The event is expected to draw key stakeholders from the clean energy sector, government, academia, and media, and will showcase the real-world implementation of Eco Wave Power's patented wave energy technology.
 &nbsp;

WAVE

Eco Wave Power Sets September 9 Launch For First Onshore U.S. Wave Energy Pilot At Port of Los Angeles

Preclinical data demonstrate potent single-agent and combination effects in head and neck squamous cell carcinoma (HNSCC) models, including synergy with anti–PD-1 therapy
Initial Phase 1 clinical update shows early disease control in first HPV+ patient treated with APR-1051
DOYLESTOWN, Pa., June 25, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APRE#NASDAQ">APRE</a>) ("Aprea", or the "Company"), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities&nbsp;while minimizing damage to healthy cells, today announced new preclinical data and a clinical update on APR-1051, the Company's next-generation oral WEE1 inhibitor, in human papillomavirus–positive (HPV+) head and neck squamous cell carcinoma (HNSCC).
These findings result from an ongoing translational research collaboration with renowned oncology leader MD Anderson Cancer Center and support the potential of APR-1051 both as a single agent and in rational immunotherapy combinations for biomarker-driven treatment of HPV+ HNSCC. "We are excited by the preclinical data generated by independent researchers, and the early clinical signal of APR-1051 in an HPV-positive cancer patient," said Oren Gilad, Ph.D., President and Chief Executive Officer of Aprea Therapeutics. "We believe that APR-1051 could offer significant differentiation in the competitive oncology landscape, as a single agent, as well as in combination with checkpoint inhibitors."

Biotech

General

APRE

Aprea Therapeutics Presents APR-1051 Preclinical And Early Clinical Results In HPV+ Head And Neck Cancer

VEEV

Veeva Expands AWS Relationship

LiqTech International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIQT#NASDAQ">LIQT</a>), a leading clean technology company that manufactures and markets highly specialized filtration technologies, today announced it has received an order for the delivery of an advanced membrane-based filtration system to treat oily wastewater from North Star BlueScope Steel, a major U.S.-based steel producer.
The system, designed to resolve recurring filtration process upsets caused by high oil content and variability in wastewater quality, is scheduled to be commissioned and begin operation in the second half of calendar year 2025.
The wastewater filtration solution uses LiqTech's robust Silicon Carbide (SiC) membrane technology designed to withstand harsh industrial water conditions and deliver consistent, high-quality filtration. This ceramic ultrafiltration system will serve as a critical pre-treatment step to a downstream reverse osmosis system, enhancing overall process stability and water recovery efficiency.
While crossflow filtration is the most sustainable wastewater treatment process, it comes with a major volume-in to volume-out challenge. LiqTech's ceramics-based system addresses this challenge while adapting to ever-changing oil and turbid water quality.
Fei Chen, CEO of LiqTech, commented: "We are proud to support North Star BlueScope Steel with our proven solution to a complex challenge. This project demonstrates our growing traction in industrial water treatment and our ability to contribute meaningfully to our customers' operational efficiency and sustainability goals."
Tony Grant, Services Senior Mechanic, North Star BlueScope Steel, added: "North Star's proximity to the Great Lakes keeps responsible water use top-of-mind for our entire team. We are excited to see how LiqTech's technology will further enable our water preservation efforts through enhancements to our water recovery technology."
The addition of advanced wastewater pre-treatment filtration supports North Star's broader water reclamation initiatives and reflects a growing trend in the steel industry toward more sustainable water management practices.

Contracts

LIQT

Liqtech Internationa Announces It Has Received An Order For Delivery Of An Advanced Membrane-Based Filtration System To Treat Oily Wastewater From North Star Bluescope Steel

Canalevia&#xAE; (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs
Jaguar is exploring the possibility of approval of Canalevia for treatment of general diarrhea in dogs in the EU based on the statistically significant data from a completed study
Diarrhea is one of the most common reasons owners bring their dog to the veterinarian and the second most common reason for visits to the veterinary emergency hospital, yet there are currently no FDA-approved drugs to treat general diarrhea in dogs
Company strategy: In discussions with multiple potential animal health company partners to collaborate to bring Canalevia to regulatory approval and commercialization for general diarrhea globally
SAN FRANCISCO, CA / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / June 25, 2025 / <a href="https://pr.report/bt7v">Jaguar Health, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) (Jaguar), under its Jaguar Animal Health tradename for the veterinary market, today announced that the company plans to pursue approval from the European Medicines Agency's (EMA) <a href="https://pr.report/bt7x">Committee for Veterinary Medicinal Products</a> (CVMP) for Canalevia (crofelemer delayed-release tablets) in the European Union for treatment of general diarrhea in dogs. Canalevia, under the name <a href="https://pr.report/bt7y">Canalevia-CA1</a>, is conditionally approved by the U.S. Food and Drug Administration (FDA) as a prescription drug for the treatment of chemotherapy-induced diarrhea (CID) in dogs.

JAGX

Jaguar Health Pursues EU Approval For Canalevia To Treat General Dog Diarrhea

Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) transformation from a speculative digital experiment into a sophisticated macroeconomic asset is reshaping the crypto and financial markets alike, according to a new Glassnode report.
What Happened: In a <a href="https://get.glassnode.com/bitcoin-liquidity-trends-report-2025/">joint report</a>, Glassnode and Avenir Group outline how Bitcoin's growing institutional maturity, structural liquidity and macro alignment position it as a serious contender on the global stage.
Bitcoin&#8217;s Institutional Maturation
<ul class="wp-block-list">
<li>Institutional adoption has reached unprecedented levels, thanks to catalysts like the U.S. spot Bitcoin ETFs, dubbed by analysts as "the most successful ETF launch in history."</li>
<li>Since November 2022, Bitcoin has absorbed over $544 billion in new capital, propelling internal liquidity to a record $944 billion, just shy of the $1 trillion milestone.</li>
<li>This marks a defining shift from retail-driven cycles to one dominated by institutional capital and macro forces.</li>
</ul>
Bitcoin's historical performance has shown a stark similarity to current levels.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>2015-2018 Current Performance</td>
<td>+1,059%</td>
</tr>
<tr>
<td>2018-2022 Current Performance</td>
<td>+1,007%</td>
</tr>
<tr>
<td>2022+ Current Performance</td>
<td>+656%</td>
</tr>
</tbody>
</table>
</figure>
Market Infrastructure Deepens
<ul class="wp-block-list">
<li>Centralized exchanges now support billions in daily BTC volume, with peak inflows/outflows reaching $11.3 billion in a single day during the 2022 cycle.</li>
<li>Derivatives markets are thriving, total futures and options open interest ballooned from $11.1 billion (December 2022) to $114 billion during Bitcoin's recent $100,000 breakout.</li>
<li>Advanced analytics like order book imbalances and cumulative volume delta (CVD) are now integral, signaling a highly sophisticated market microstructure.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46089127/arthur-hayes-doubles-down-on-250000-bitcoin-call-sees-1-million-by-2028">Arthur Hayes Doubles Down On $250,000 Bitcoin Call — Sees $1 Million By 2028</a>
Among other contributing factors responsible for Bitcoin's shaping,
Macro Integration Strengthens
<ul class="wp-block-list">
<li>Bitcoin's correlation with major financial indices like the (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NASDAQ">SPY</a>), (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), gold and the global liquidity Index is rising, showing it trades like a true risk asset.</li>
<li>In contrast, Bitcoin's negative correlation with defensive assets like the dollar index and junk bond spreads indicates its role in expansionary cycles.</li>
<li>This reflects a new identity for Bitcoin, no longer just a speculative bet, but a leveraged play on global liquidity.</li>
</ul>
Altcoin Divergence Emerges
<ul class="wp-block-list">
<li>Despite strong crypto market growth, only Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) and XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) have outperformed Bitcoin among large-cap coins since January 2023.</li>
<li>Ethereum's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) dominance has waned in the current cycle, as liquidity spreads more broadly and BTC captures the bulk of institutional flows.</li>
<li>Bitcoin's market cap has grown 728% this cycle, compared to 500% for altcoins, highlighting BTC&#8217;s outperformance.</li>
</ul>
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Change From</td>
<td>Change To</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$170.7 billion</td>
<td>$67.6 billion</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$33.9 billion</td>
<td>$54.9 billion</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$25.7 billion</td>
<td>$11.4 billion</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$15.3 billion</td>
<td>$38.6 billion</td>
</tr>
<tr>
<td>BNB (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>)</td>
<td>$11.8 billion</td>
<td>$31.1 billion</td>
</tr>
<tr>
<td>Tron (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/trx/usd">TRX</a>)</td>
<td>$3.3 billion</td>
<td>$9.9 billion</td>
</tr>
<tr>
<td>Toncoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TON</a>)</td>
<td>$500 million</td>
<td>$4.6 billion</td>
</tr>
</tbody>
</table>
</figure>
With scale, regulatory clarity, and macro alignment, Bitcoin is now positioned more like gold or equities than a typical crypto token, the report concludes.
It's not just a digital asset anymore, it&#8217;s becoming a cornerstone of macro portfolios, attracting deep institutional capital and setting itself apart from the rest of the crypto landscape.
Read Next: &nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46081761/bitcoin-dominance-tops-65-but-altcoin-season-is-close-trader-says">Bitcoin Dominance Tops 65% But &#8216;Altcoin Season&#8217; Is Close, Trader Says</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BNB

$BTC

$DOGE

$ETH

$SOL

$TON

$TRX

$XRP

How Bitcoin Is Maturing To A Global Liquidity Asset: Report

Barclays analyst Julien Roch downgrades WPP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPP#NYSE">WPP</a>) from Equal-Weight to Underweight.

Downgrades

Barclays Downgrades WPP to Underweight

INVO Fertility, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVF#NASDAQ">IVF</a>) ("INVO Fertility" or the "Company"), a healthcare company focused on the fertility sector, today announced it has received a notice of allowance on a new patent for a modified version of the Company's proprietary INVOcell device. The new patent extends intellectual property protection on the Company's INVOcell device through 2040 based on a modified design which reflects feedback from leading embryologists to simplify use of the device.
The United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 16/949,960, titled "Intravaginal Culture Incubation Container and Method." The Notice of Allowance, dated June 17, 2025, indicates that the USPTO has completed its examination and found the claims patentable. Once the issue fee is paid, the patent will be granted and published, providing protection to the claimed invention for 20 years from the filing date.
INVOcell is the world's first FDA-cleared intravaginal culture (IVC) system, a patented medical device that enables fertilization and early embryo development to occur within a woman's body, offering a more natural and intimate alternative to traditional in vitro fertilization (IVF). During the INVOcell procedure, eggs and sperm are placed in the thumb-sized device, which is then inserted into the vaginal cavity, typically, for a 5-day incubation period, utilizing the body's natural environment as an incubator. After incubation, embryos are transferred to the uterus, with any remaining embryos available for freezing. This innovative approach delivers comparable pregnancy rates to IVF—as reflected in the Company's 510k submission that was cleared by the FDA in 2023.
INVOcell was originally granted FDA clearance in 2015 and, in 2023, received clearance from the FDA for a change in labeling that increased the incubation period from 3 days to 5 days. The original INVOcell device included both a main chamber and microchamber. As real-world use cases of INVOcell have occurred over the past number of years, feedback from embryologists highlighted a preference for a singular main chamber without a separate microchamber. The Company redesigned the INVOcell device to reflect the feedback and subsequently submitted a modified device design for patent.
"The INVOcell device has represented a unique and alternative fertility treatment option, offering a more patient-centered approach that empowers couples by allowing fertilization and early embryo development to occur within the woman's body," commented Steve Shum, CEO of INVO Fertility. "The receipt of a new patent for our simplified device expands our intellectual property protection to this innovative approach, which delivers success rates comparable to traditional IVF, helping to make parenthood more accessible and inclusive for those facing infertility challenges worldwide."

INVO Fertility Announces It Received Notice Of Allowance For Modified INVOcell Device Patent

WIIM

INDP

Indaptus Therapeutics shares are trading lower after the company announced it will effect a reverse stock split at a ratio in the range of 1-for-5 and 1-for-28.

RBNE

Robin Energy shares are trading lower after the company announced the pricing of a 1,020,000 share registered direct offering at $3.50 per share.

XTIA

XTI Aerospace shares are trading lower after the company announced the pricing of a $16 million offering of 9,143,000 shares and 9,143,000 warrants at $1.75 per share and Common Warrant.

Management

ULTA

Ulta Beauty Appoints Chris Lialios Interim CFO

Robin Energy Ltd. Announces Pricing Of 1,020,000 Share Registered Direct Offering At Price Of $3.50

Barclays analyst Julien Roch downgrades Omnicom Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMC#NYSE">OMC</a>) from Overweight to Equal-Weight and lowers the price target from $105 to $80.

Barclays Downgrades Omnicom Group to Equal-Weight, Lowers Price Target to $80

First Citizens BancShares's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NYSE">FCNCA</a>) short percent of float has risen 12.03% since its last report. The company recently reported that it has 448 thousand shares sold short, which is 4.75% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.74 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>First Citizens BancShares Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750856434_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for First Citizens BancShares has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing First Citizens BancShares's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, First Citizens BancShares's peer group average for short interest as a percentage of float is 1.70%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

FCNCA

Is First Citizens BancShares Gaining or Losing Market Support?

WEC Energy Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEC#NYSE">WEC</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $108.25, along with a high estimate of $124.00 and a low estimate of $100.00. This current average has increased by 1.64% from the previous average price target of $106.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1750856433_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of WEC Energy Group by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Carly Davenport</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$100.00</td>
<td>$106.00</td>
</tr>
<tr>
<td>Neil Kalton</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$124.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Nicholas Campanella</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$101.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Jeremy Tonet</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$108.00</td>
<td>$106.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to WEC Energy Group. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of WEC Energy Group compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of WEC Energy Group's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of WEC Energy Group's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WEC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on WEC Energy Group analyst ratings.</a>
<h2>Unveiling the Story Behind WEC Energy Group</h2>
WEC Energy Group's electric and gas utility businesses serve electric and gas customers in Illinois, Michigan, Minnesota, and Wisconsin service territories. The company also owns a 60% stake in American Transmission Co. WEC's asset mix is approximately 49% electric generation and distribution, 34% gas distribution, 10% electric transmission, and 7% unregulated renewable energy.
<h3>WEC Energy Group: Delving into Financials</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: WEC Energy Group's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 17.51%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Utilities sector.
Net Margin: WEC Energy Group's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 22.99%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): WEC Energy Group's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.71%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): WEC Energy Group's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.52%, the company showcases efficient use of assets and strong financial health.
Debt Management: WEC Energy Group's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.58.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing WEC Energy Group: Insights From 4 Financial Analysts

Energy Transfer's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) short percent of float has fallen 6.06% since its last report. The company recently reported that it has 28.67 million shares sold short, which is 0.93% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.96 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Energy Transfer Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750856429_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Energy Transfer has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Energy Transfer's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Energy Transfer's peer group average for short interest as a percentage of float is 3.66%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on Energy Transfer?

Entertainment

Press Releases

iQIYI announces the groundbreaking of its first comprehensive theme park, leveraging IP-driven offline experiences to boost growth

iQIYI hosts Glittering Night to drive high-quality development in mini and short drama industry

iQIYI Files Its Annual Report on Form 20-F

From screen to society: latest iQIYI-presented films champion realism in cinematic storytelling

iQIYI leads agile, IP-and tech-powered offline experience with plan for second theme park in China

iQIYI to Report First Quarter 2025 Financial Results on May 21, 2025

iQIYI 2025 World Conference: Shaping the future of online entertainment through integrated "long + short" storytelling and enhanced IP monetization

Earnings

iQIYI Announces First Quarter 2025 Financial Results

iQIYI pioneers digital asset commercialization, leading the charge in scalable virtual production

iQIYI celebrates fifth annual Golden Screenwriters' Night, advancing stronger industry ecosystem for screenwriting talent

AMC Entertainment Holdings, Inc. Class A Common Stock

AMC Entertainment Hldgs

Atlanta Braves Holdings, Inc. - Series A Common Stock

Atlanta Braves Holdings

Atlanta Braves Holdings, Inc. - Series C Common Stock

Cinemark Holdings Inc Cinemark Holdings, Inc. Common Stock

Cinemark Holdings

CuriosityStream Inc. - Class A Common Stock

CuriosityStream

Walt Disney

Liberty Media Corporation - Series A Liberty Formula One Common Stock

Liberty Media

Ordinary Shares (New Liberty Formula One) Series A

Liberty Media Corporation - Series C Liberty Formula One Common Stock

Ordinary Shares (New Liberty Formula One) Series C

Lionsgate Studios

Liberty Media Corporation - Series A Liberty Live Common Stock

Liberty Live

Ordinary Shares (New Liberty Live) Series A

Liberty Media Corporation - Series C Liberty Live Common Stock

Ordinary Shares (New Liberty Live) Series C

Live Nation Entertainment, Inc. Common Stock

Live Nation Entertainment

Manchester United Ltd. Class A Ordinary Shares

Manchester United

Marcus

Madison Square Garden Entertainment Corp. Class A Common Stock

Madison Square Garden

Madison Square Garden Sports Corp. Class A Common Stock (New)

Netflix

Roku

Reservoir Media

Sphere Entertainment Co. Class A Common Stock

Sphere Entertainment

Starz Entertainment Corp. - Common Shares

Starz Entertainment

TKO Group Holdings, Inc. Class A Common Stock

TKO Group Holdings

Tencent Music Entertainment Group American Depositary Shares, each representing two Class A Ordinary Shares

Comments

iQIYI

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL